DRI Healthcare Trust (DHT.UN) Stock Price, News & Analysis

Company Overview

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence in the United States; European Union; Japan, and Rest of the world.

Key Stats

• Today's Range: C$13.30 to C$13.47
• 50-Day Range: C$11.25 to C$13.65
• 52-Week Range: C$10.39 to C$15.45
• Volume: 12,885 shs
• Average Volume: 45,108 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 3.44%
• Price Target: C$18.07
• Consensus Rating: Moderate Buy

DRI Healthcare Trust Stock Analysis - MarketRank™

DRI Healthcare Trust scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

DRI Healthcare Trust has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

DRI Healthcare Trust has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of DRI Healthcare Trust is -267.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of DRI Healthcare Trust is -267.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

DRI Healthcare Trust has a P/B Ratio of 1.43. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for DHT.UN.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

DRI Healthcare Trust pays a meaningful dividend of 3.26%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

DRI Healthcare Trust does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for DHT.UN.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for DRI Healthcare Trust this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, DRI Healthcare Trust insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.14% of the stock of DRI Healthcare Trust is held by insiders.

Percentage Held by Institutions

48.42% of the stock of DRI Healthcare Trust is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DHT.UN Stock Analysis - Frequently Asked Questions

How have DHT.UN shares performed this year?

DRI Healthcare Trust's stock was trading at C$11.83 at the start of the year. Since then, DHT.UN shares have increased by 13.0% and is now trading at C$13.37.

How do I buy shares of DRI Healthcare Trust?

Shares of DHT.UN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: TSE:DHT.UN
• CIK: N/A
• Web: www.dricapital.com
• Phone: 416-863-1865
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$18.07
• High Stock Price Target: C$22.00
• Low Stock Price Target: C$14.00
• Potential Upside/Downside: +35.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): C($0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 21.04
• P/E Growth: N/A
• Net Income: C$9.73 million
• Net Margins: 5.02%
• Pretax Margin: N/A
• Return on Equity: 2.06%
• Return on Assets: 4.22%

Debt

• Debt-to-Equity Ratio: 63.20
• Current Ratio: 1.36
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$193.66 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$9.32 per share
• Price / Book: 1.43

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: 0.60